Literature DB >> 2040480

Undetectable caeruloplasmin values in a patient with autoimmune chronic active hepatitis.

Y Ilan1, M Hillman, R Oren, E Galun, M Shalit.   

Abstract

Caeruloplasmin is an alpha 2 protein produced in the liver that is responsible for transporting copper in the blood. Caeruloplasmin values are usually high in patients with chronic liver diseases, including chronic active hepatitis: low values, however, are characteristic of Wilson's disease. The case of a 17 year old woman with very low caeruloplasmin values and chronic active hepatitis of the lupoid type is described. Steroid treatment resulted in an increase in the caeruloplasmin concentration and clinical improvement.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040480      PMCID: PMC1378937          DOI: 10.1136/gut.32.5.549

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  7 in total

1.  Caeruioplasmin in liver disease. A diagnostic pitfall.

Authors:  J M WALSHE; J BRIGGS
Journal:  Lancet       Date:  1962-08-11       Impact factor: 79.321

2.  The mechanism of copper deposition in the liver in hepatolenticular degeneration (Wilson's disease).

Authors:  L L UZMAN; F L IBER; T C CHALMERS
Journal:  Am J Med Sci       Date:  1956-05       Impact factor: 2.378

3.  Chronic hepatitis as a first manifestation of Wilson's disease.

Authors:  I Sternlieb; I H Scheinberg
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

Review 4.  Copper: its role in the pathogenesis of liver disease.

Authors:  J M Walshe
Journal:  Semin Liver Dis       Date:  1984-08       Impact factor: 6.115

5.  Diagnosis of Wilson's disease.

Authors:  I Sternlieb
Journal:  Gastroenterology       Date:  1978-04       Impact factor: 22.682

6.  Wilson's disease, presenting as chronic active hepatitis.

Authors:  J Scott; J L Gollan; S Samourian; S Sherlock
Journal:  Gastroenterology       Date:  1978-04       Impact factor: 22.682

7.  Wilson's disease: diagnostic difficulties in the patient with chronic hepatitis and hypoceruloplasminemia.

Authors:  S J Spechler; R S Koff
Journal:  Gastroenterology       Date:  1980-04       Impact factor: 22.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.